Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.

Rizvi H, Paterson JC, Tedoldi S, Ramsay A, Calaminici M, Natkunam Y, Lonardi S, Tan SY, Campbell L, Hansmann ML, Jones D, Dikic I, Shaw AS, Pileri SA, Stein H, Mason DY, Facchetti F, Marafioti T.

Pathologica. 2012 Apr;104(2):56-64.

PMID:
22953501
2.

Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.

Masir N, Jones M, Abdul-Rahman F, Florence CS, Mason DY.

Pathology. 2012 Apr;44(3):228-33. doi: 10.1097/PAT.0b013e3283513fb2.

PMID:
22406486
3.

Heterogeneous expression of B cell-associated markers in follicular lymphoma.

Masir N, Jones M, Marafioti T, Mason DY.

Histopathology. 2011 Mar;58(4):633-6. doi: 10.1111/j.1365-2559.2011.03782.x. Epub 2011 Mar 3. No abstract available.

PMID:
21371078
4.

The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.

Masir N, Jones M, Lee AM, Goff LK, Clear AJ, Lister A, Marafioti T, Mason DY.

Histopathology. 2010 Apr;56(5):617-26. doi: 10.1111/j.1365-2559.2010.03524.x.

PMID:
20459572
5.

Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.

Masir N, Campbell LJ, Jones M, Mason DY.

Pathology. 2010 Apr;42(3):212-6. doi: 10.3109/00313021003631296.

PMID:
20350212
6.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.

Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M, Plonquet A, Rodriguez-Pinilla SM, Klapper W, Hansmann ML, Pileri SA, Isaacson PG, Stein H, Piris MA, Mason DY, Gaulard P.

Haematologica. 2010 Mar;95(3):432-9. doi: 10.3324/haematol.2009.010991.

7.

Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?

Mattsson G, Turner SH, Cordell J, Ferguson DJ, Schuh A, Grimwade LF, Bench AJ, Weinberg OK, Marafioti T, George TI, Arber DA, Erber WN, Mason DY.

Haematologica. 2010 Apr;95(4):670-3. doi: 10.3324/haematol.2009.011817. Epub 2009 Dec 16.

8.

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.

Rees-Unwin KS, Faragher R, Unwin RD, Adams J, Brown PJ, Buckle AM, Pettitt A, Hutchinson CV, Johnson SM, Pulford K, Banham AH, Whetton AD, Lucas G, Mason DY, Burthem J.

Br J Haematol. 2010 Feb;148(4):534-43. doi: 10.1111/j.1365-2141.2009.07979.x. Epub 2009 Nov 23.

PMID:
19961478
9.

Defining the molecular target of an antibody derived from nuclear extract of Jurkat cells using protein arrays.

Kijanka G, Barry R, Chen H, Gould E, Seidlits SK, Schmid J, Morgan M, Mason DY, Cordell J, Murphy D.

Anal Biochem. 2009 Dec 15;395(2):119-24. doi: 10.1016/j.ab.2009.08.039. Epub 2009 Sep 3.

PMID:
19733143
10.

Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.

Natkunam Y, Tedoldi S, Paterson JC, Zhao S, Rodriguez-Justo M, Beck AH, Siebert R, Mason DY, Marafioti T.

Am J Clin Pathol. 2009 Sep;132(3):361-71. doi: 10.1309/AJCPEAGDKLWDMB1O.

11.

Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues.

Ozkal S, Paterson JC, Tedoldi S, Hansmann ML, Kargi A, Manek S, Mason DY, Marafioti T.

Pathol Res Pract. 2009;205(11):781-8. doi: 10.1016/j.prp.2009.07.002. Epub 2009 Aug 3.

PMID:
19647948
12.

BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations.

Masir N, Campbell LJ, Goff LK, Jones M, Marafioti T, Cordell J, Clear AJ, Lister TA, Mason DY, Lee AM.

Br J Haematol. 2009 Mar;144(5):716-25. doi: 10.1111/j.1365-2141.2008.07528.x. Epub 2008 Dec 11.

PMID:
19120369
13.

Labeling of multiple cell markers and mRNA using automated apparatus.

Paterson JC, Ballabio E, Mattsson G, Turner SH, Mason DY, Marafioti T.

Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):371-81. doi: 10.1097/PAI.0b013e318164fc63.

PMID:
18528279
14.

Innovations in immunohistochemistry for the haematopathologist.

Mason DY.

Ann Pathol. 2007 Nov;27 Spec No 1:1S33-6. No abstract available.

PMID:
18376809
15.

Novel markers of normal and neoplastic human plasmacytoid dendritic cells.

Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY.

Blood. 2008 Apr 1;111(7):3778-92. doi: 10.1182/blood-2007-10-117531. Epub 2008 Jan 24.

PMID:
18218851
16.

Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma.

Tedoldi S, Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, Marafioti T.

J Pathol. 2007 Dec;213(4):429-40.

PMID:
17935142
17.

Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material.

Mattsson G, Tan SY, Ferguson DJ, Erber W, Turner SH, Marafioti T, Mason DY.

J Mol Diagn. 2007 Sep;9(4):479-89. Epub 2007 Aug 9.

18.

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.

Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T.

Haematologica. 2007 Aug;92(8):1059-66. Epub 2007 Jul 20.

19.

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.

Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, Lim CY, Wang Y, Marafioti T, Mason DY, Ambinder RF, Chan AT, Tao Q.

Br J Haematol. 2007 Mar;136(6):829-32.

PMID:
17341268
20.

Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma.

Masir N, Ventura R, Jones M, Marafioti T, Mason DY, Samol J.

J Clin Pathol. 2007 Sep;60(9):1061-4. Epub 2006 Dec 20. No abstract available.

21.

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, Levy R.

Blood. 2007 Feb 15;109(4):1636-42. Epub 2006 Oct 12.

22.

Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?

Natkunam Y, Mason DY.

Lab Invest. 2006 Aug;86(8):742-7. Epub 2006 Jun 19.

23.

The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.

Paterson JC, Tedoldi S, Craxton A, Jones M, Hansmann ML, Collins G, Roberton H, Natkunam Y, Pileri S, Campo E, Clark EA, Mason DY, Marafioti T.

Haematologica. 2006 Jun;91(6):772-80.

24.

Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.

Tedoldi S, Paterson JC, Cordell J, Tan SY, Jones M, Manek S, Dei Tos AP, Roberton H, Masir N, Natkunam Y, Pileri SA, Facchetti F, Hansmann ML, Mason DY, Marafioti T.

J Pathol. 2006 Aug;209(4):454-63.

PMID:
16739114
25.

The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells.

Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H, Tucker PW, Roncador G, Lucas E, Ashe S, Stockwin L, Walewska R, Karran L, Gascoyne RD, Mason DY, Dyer MJ.

Leukemia. 2006 Aug;20(8):1439-41. Epub 2006 May 18. No abstract available.

PMID:
16710303
26.

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, Siebert R.

J Mol Diagn. 2006 May;8(2):141-51. Review.

27.

PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.

Garcia JF, Roncador G, García JF, Sánz AI, Maestre L, Lucas E, Montes-Moreno S, Fernandez Victoria R, Martinez-Torrecuadrara JL, Marafioti T, Mason DY, Piris MA.

Haematologica. 2006 Apr;91(4):467-74.

28.

Loss of CD19 expression in B-cell neoplasms.

Masir N, Marafioti T, Jones M, Natkunam Y, Rüdiger T, Hansmann ML, Mason DY.

Histopathology. 2006 Feb;48(3):239-46.

PMID:
16430470
29.
30.

Transmembrane adaptor molecules: a new category of lymphoid-cell markers.

Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Rüdiger T, Angelisova P, Du MQ, Roberton H, Roncador G, Sanchez L, Pozzobon M, Masir N, Barry R, Pileri S, Mason DY, Marafioti T, Horejsí V.

Blood. 2006 Jan 1;107(1):213-21. Epub 2005 Sep 13.

PMID:
16160011
31.

Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.

Campo E, Mason DY.

Haematologica. 2005 Mar;90(3):292. No abstract available.

PMID:
15749656
32.

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.

Marafioti T, Pozzobon M, Hansmann ML, Gaulard P, Barth TF, Copie-Bergman C, Roberton H, Ventura R, Martín-Subero JI, Gascoyne RD, Pileri SA, Siebert R, Hsi ED, Natkunam Y, Möller P, Mason DY.

Leukemia. 2005 May;19(5):856-61.

PMID:
15744341
33.

The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.

Marafioti T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TF, Du MQ, Leoncini L, Möller P, Natkunam Y, Siebert R, Mason DY.

Br J Haematol. 2005 Feb;128(3):333-42. Erratum in: Br J Haematol. 2005 Apr;129(1):162. Marafiot, Teresa [corrected to Marafioti, Teresa].

PMID:
15667535
34.

Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells.

Masir N, Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV, Hansmann ML, Natkunam Y, Taranin AV, Mason DY.

Br J Haematol. 2004 Nov;127(3):335-43.

PMID:
15491296
35.

Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma.

Ventura RA, Martin-Subero JI, Knippschild U, Gascoyne RD, Delsol G, Mason DY, Siebert R.

Leukemia. 2004 Nov;18(11):1910-1. No abstract available.

PMID:
15385940
36.

Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani PL, Pozzobon M, Pulford K, Falini B, Jaffe ES, Müller-Hermelink HK, Mason DY, Pileri SA.

Haematologica. 2004 Aug;89(8):957-64.

37.

Immunofluorescent and FISH analysis of skin biopsies.

Gellrich S, Ventura R, Jones M, Tan SY, Mason DY.

Am J Dermatopathol. 2004 Jun;26(3):242-7. Review.

PMID:
15166516
38.

The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas.

Pileri SA, Marafioti T, Pozzobon M, Sabattini E, Ascani S, Mancini C, Piccioli M, Hansmann ML, Delsol G, Mason DY.

Pathologica. 2003 Oct;95(5):227. No abstract available.

PMID:
14988978
39.

Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.

Pozzobon M, Marafioti T, Hansmann ML, Natkunam Y, Mason DY.

Br J Haematol. 2004 Feb;124(4):519-33.

PMID:
14984504
40.

Tyrosine phosphorylation in human lymphomas.

Haralambieva E, Jones M, Roncador GM, Cerroni L, Lamant L, Ott G, Rosenwald A, Sherman C, Thorner P, Kusec R, Wood KM, Campo E, Falini B, Ramsay A, Marafioti T, Stein H, Kluin PM, Pulford K, Mason DY.

Histochem J. 2002;34(11-12):545-52.

PMID:
14626344
41.

Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease.

Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY.

Blood. 2004 Jan 1;103(1):188-93. Epub 2003 Jul 24.

PMID:
12881301
42.

Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology.

Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG, Pozzobon M, Pileri SA, Strickson AJ, Tan SY, Watkins F, Mason DY.

Blood. 2003 Oct 15;102(8):2868-76. Epub 2003 Jun 26.

PMID:
12829584
43.

Human Leucocyte Differentiation Antigen nomenclature: update on CD nomenclature. Report of IUIS/WHO Subcommittee.

Zola H, Swart B, Boumsell L, Mason DY; IUIS/WHO Subcommittee.

J Immunol Methods. 2003 Apr 1;275(1-2):1-8.

PMID:
12723570
44.

Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples.

Haralambieva E, Banham AH, Bastard C, Delsol G, Gaulard P, Ott G, Pileri S, Fletcher JA, Mason DY.

Br J Haematol. 2003 Apr;121(1):49-56.

PMID:
12670331
45.

Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

Marafioti T, Ascani S, Pulford K, Sabattini E, Piccioli M, Jones M, Zinzani PL, Delsol G, Mason DY, Pileri SA.

Am J Pathol. 2003 Mar;162(3):861-71.

46.

Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.

Marafioti T, Jabri L, Pulford K, Brousset P, Mason DY, Delsol G.

Br J Haematol. 2003 Feb;120(4):671-8.

PMID:
12588355
47.

Cytokeratin expression in smooth muscle and smooth muscle tumours.

Brown DC, Theaker JM, Banks PM, Gatter KC, Mason DY.

Histopathology. 2002 Sep;41(3A):85-94. No abstract available.

PMID:
12405935
48.
49.

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Müller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM.

Histopathology. 2002 Jul;41(1):1-29.

PMID:
12121233
50.

CD antigens 2001.

Mason DY, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsí V, Meuer S, Morissey J, Schwartz-Albiez R, Shaw S, Simmons D, Uguccioni M, van der Schoot E, Viver E, Zola H.

Tissue Antigens. 2001 Dec;58(6):425-30. Review.

PMID:
11929596

Supplemental Content

Loading ...
Support Center